Research //

NIHR invests £34 million into global health research on epilepsy, infection-related cancers and severe stigmatising skin diseases

The NIHR has invested £34 million of funding into global health research projects to tackle epilepsy, infection-related cancers and severe stigmatising skin diseases in low- and middle-income countries (LMICs).

The NIHR Research and Innovation for Global Health Transformation (RIGHT) programme has awarded Official Development Assistance (ODA) funding to eight projects led by teams made up of researchers in the UK and those in LMICs.

Continue Reading

To access this content please register.

Register for Free

Already a member? Login

Please register or login to comment!

Register now Login

Select a page to copy this section to:

Select where in the level you want it inserted: